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Purpose: Our previous work identified 23 low molecular weight (<3.5 kDa) crystallin peptides in the urea-soluble fractions
of normal young, normal aged, and aged cataract human lenses. We found that one of these crystallin fragments, βA3/
A1102–117 peptide (SDAYHIERLMSFRPIC), that are present in aged and cataract lens, increased the scattering of light by
β- and γ-crystallins and alcohol dehydrogenase (ADH) and also reduced the chaperone-like activity of αB-crystallin. The
present study was performed to identify the interacting sites of the βA3/A1102–117 peptide in αB-crystallin.
Methods: βA3/A1102–117 peptide was first derivatized with sulfo-succinimidyl-2-[6-(biotinamido)-2-{p-
azidobenzamido}-hexanoamido] ethyl-1–3 dithio propionate (sulfo-SBED), a photoactivable, heterotrifunctional biotin-
containing cross-linker. The biotin-derivatized peptide was then incubated with αB-crystallin at 37 °C for 2 h to allow
complex formation followed by photolysis to facilitate the transfer of the biotin label from the peptide to αB-crystallin.
Label transfer was confirmed by western blot, and the labeled αB-crystallin was digested with trypsin. Tryptic peptides
from αB-crystallin carrying the biotin label were purified by avidin affinity chromatography, and βA3/A1102–117 peptide
interacting sites in αB-crystallin were identified by matrix-assisted laser desorption ionization-time-of-flight mass
spectrometry (MALDI-TOF MS) and nanospray quadrupole time-of-flight mass spectrometry (QqTOF MS/MS).
Results: We found that the βA3/A1102–117 peptide interacted with αB-crystallin regions 70LEKDR74, 83HFSPEELKVK92,
91VKVLGDVIEVHGK103, 93VLGDVIEVHGKHEER107, and 121KYR123, which are part of the α-crystallin domain, and
were previously shown to be part of the functional chaperone site in αB-crystallin. The βA3/A1102–117 peptide also
interacted with regions at the COOH-terminal extension of αB-crystallin, 150KQVSGPER157, 164EEKPAVTAAPK174, and
164EEKPAVTAAPKK175. When two of the hydrophobic residues of βA3/A1102–117 peptide were replaced with hydrophilic
residues, the resulting substituted peptide, SDADHGERLMSFRPIC, did not show the anti-chaperone property.
Conclusions: This study confirmed the interactions between a low molecular weight peptide derived from βA3/A1-
crystallin found in aged and cataract lenses and αB-crystallin. The binding of βA3/A1102–117 peptide to the chaperone site
and the COOH-terminal extension of αB-crystallin may explain its anti-chaperone property.
Human lens crystallins are organized into three classes,
α-, β-, and γ-crystallins, based on sequence homology and the
size of aggregates isolated under physiologic conditions.
Since lens crystallins undergo little or no turnover, there is
opportunity for numerous post-translational modifications as
the lens ages [1-4]. Some modifications of lens crystallins
identified in young clear lenses may reflect normal
development and maturation of the lens [5,6] whereas other
modifications associated with aged lenses- such as
deamidation, phosphorylation, truncation, glycation,
oxidation, and cross-linking could negatively impact
crystallin conformation, aggregation state, or solubility,
resulting in increased light scattering and eventual loss of
transparency in aged lenses [7-10].
In comparison to normal lenses, cataract lenses show
greater fragmentation of crystallins due to proteolysis [1,
11-13]. Increased crystallin fragmentation has also been
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reported in aged and cataract lenses of non-human species
[6,14-17]. It has been reported that proteolysis may be a
contributing factor in the insolubilization of crystallins
occurring during normal maturation of lens or during cataract
formation in human and bovine lenses [18]. It has been shown
that the fragments of βA3/A1- and βB1-crystallins are
selectively insolubilized during cataract development
compared to normal aging [13]. These authors also reported
increased crystallin truncation, the deamidation of Asn to Asp
residues, and the oxidation of a Trp residue in cataract lenses.
Several proteolytic enzymes have been shown to play a
role in aging of the lens and cataract formation [19-25].
Activities of several peptidases were reported to be highest in
the outer cortical fibers and decreased to one half or below in
the inner cortical fibers and nucleus. An inverse correlation
between peptidase activities and the amount of crystallin
fragments was observed in different regions of the lens. The
amount of crystallin fragments and the amount of water-
insoluble proteins were greater in the lens nucleus than in the
outer cortical fibers [21]. An age-dependent decline in
proteasome activity and a concomitant accumulation of
Molecular Vision 2008; 14:666-674 <http://www.molvis.org/molvis/v14/a80>
Received 31 January 2008 | Accepted 21 March 2008 | Published 26 March 2008
© 2008 Molecular Vision
666
modified proteins in human lens has been reported earlier
[26]. Increased opacification of the lens nucleus in cataract
was significantly correlated with decreased peptidase
activities of the proteasome [27]. Although a protein oxidation
reaction may render the protein susceptible to proteolysis,
heavily oxidized proteins appear to first aggregate (via new
hydrophobic and ionic bonds) and then to form covalent cross-
links that make them highly resistant to proteolysis by 20S
proteasome [28]. In fact, these aggregated, cross-linked
oxidized proteins actually bind to the 20S proteasome and
inhibit its ability to degrade the oxidized forms of other
proteins [29].
Low molecular weight crystallin fragments have been
isolated and characterized from both the water-soluble and
water-insoluble fractions of the lens with greater prevalence
in the water-insoluble fractions [11,21,30-32]. As many as 13
crystallin fragments with molecular masses between 3 and 17
kDa and originating from α-, β-, and γ-crystallins have been
isolated from the water-soluble, high molecular weight
aggregates of 60-80-year-old human lenses [31].
Accumulation of such crystallin fragments may be a cause for
age-related lens opacity. It has been hypothesized that the
interaction of short peptides derived from crystallins with lens
proteins may increase the formation of high molecular weight
aggregates and the scattering of light [33]. Though it is
hypothesized that cataract develops as a result of improper
interaction of crystallin fragments generated by proteolysis
[25], the underlying mechanism is not clear. Earlier work by
our group has shown that in vitro-oxidized crystallin peptides
enhance the aggregation of βL-crystallin and γ-crystallin and
also exhibit anti-chaperone-like properties [33-35].
Interaction of peptide fragments with lens proteins and their
aggregation-enhancing nature may have some implications
for age-related cataract formation.
Recent studies in our laboratory have revealed the
presence of 23 low molecular weight (<3.5 kDa) peptides in
the urea-soluble fractions of normal young, normal aged, and
aged cataract human lenses, and the amount of crystallin
fragments was found to increase with age [36]. Out of these
23 peptides, 15 were derived from αA- and αB-crystallin.
Most of the 15 came from the NH2-terminal region, a few from
the α-crystallin domain, and none from the COOH-terminal
extension. Two crystallin peptides predominant in the nucleus
of aged lens and cataract lens but not in young lens, αB1–18
(MDIAIHHPWIRRPFFPFH, GenBank NP_001876) and
βA3/A1102–117 (SD(N)AYHIERLMSFRPIC, GenBank
NP_005199), increased the molecular mass, polydispersity,
and hydrodynamic radius of αA- and αB-crystallins [36]. Our
study also showed that the peptides, αB1–18 and βA3/A1102–
117, increased the scattering of light by β- and γ-crystallins and
alcohol dehydrogenase (ADH) and also reduced the
chaperone-like activity of α-crystallin.
The present study was undertaken to identify the binding
sites for the βA3/A1102–117 peptide in αB-crystallin. We used
the photoactive cross-linker sulfo-SBED (sulfo-
succinimidyl-2-[6-(biotinamido)-2-{p-azidobenzamido}-
hexanoamido] ethyl-1–3 dithio propionate) [37] to confirm
the interaction between αB-crystallin and the βA3/A1102–117
peptide. The βA3/A1102–117 peptide interacting sites in αB-
crystallin are reported here.
METHODS
Reagents: Trypsin gold (mass spectrometry grade) was
purchased from Promega Corporation (Madison, WI). Sulfo-
SBED, immobilized monomeric avidin kit, and micro-
bicinchoninic acid (BCA) protein assay kit were procured
from Pierce (Rockford, IL). Trypsin inhibitor, TLCK (N α-p-
tosyl-L-lysine chloromethyl ketone), was obtained from
Sigma Chemical Company (St. Louis, MO). The βA3/A1102–
117 peptide, SDAYHIERLMSFRPIC, and the substituted
peptide, SDADHGERLMSFRPIC (in which the tyrosine and
isoleucine corresponding to 105 and 107 in βA3/A1-crystallin
are replaced by aspartate and by glycine, respectively), were
synthesized at the University of Missouri core facility and
purified by HPLC. Their masses (1936.9 Da and 1833 Da,
respectively) were ascertained by matrix-assisted laser
desorption ionization-time-of-flight mass spectrometry
(MALDI-TOF MS). Blotting grade avidin-horseradish
peroxidase conjugate was obtained from Bio-Rad
Laboratories (Hercules, CA). Bovine βL-crystallin was
isolated from lens extract using the procedure described
earlier [35]. All other chemicals were of analytical grade.
Synthesis of recombinant human αB-crystallin: Human αB-
crystallin cDNA (obtained from J.M. Petrash, Washington
University, St. Louis, MO) was cloned into the pET-23d (+)
vector (Novagen, Madison, WI), and the recombinant protein
was expressed in Escherichia coli BL21(DE3) pLysS cells
(Invitrogen, Carlsbad, CA) as described earlier [38]. The
protein was purified by size exclusion chromatography
followed by ion-exchange chromatography as described
previously [39].
Effect of βA3/A1102–117 peptide on the thermal aggregation of
βL-crystallin and the chaperone function of αB-crystallin: The
βA3/A1102–117 peptide (SDAYHIERLMSFRPIC) as well as
the substituted peptide (SDADHGERLMSFRPIC) were
dissolved in 50 μl of DMSO and diluted to 0.5 ml with 0.05
M phosphate buffer containing 0.15 M NaCl (pH 7.4),
hereafter referred to as phosphate buffered saline (PBS). The
peptide concentration was measured using the micro-BCA
assay method. Thermal aggregation assay of bovine βL-
crystallin and chaperone assay of αB-crystallin were
performed according to the method previously described
[35]. Briefly, substrate protein, βL-crystallin (100 μg), was
heat-denatured at 55 °C in 1 ml of PBS for 60 min in the
presence or absence of αB-crystallin (5 μg) and the βA3/
A1102–117 peptide or the substituted peptide (60 μg).
Aggregation was monitored by recording the light scattering
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at 360 nm as a function of time at 55 °C in a Shimadzu
spectrophotometer equipped with a temperature-controlled
multicell transporter.
Effect of pre-incubation with βA3/A1102–117 peptide on the
chaperone function of αB-crystallin: To determine whether
prior binding of the βA3/A1102–117 peptide alters the
chaperone-like activity of αB-crystallin toward denaturing
proteins, 50 μg of αB-crystallin was incubated with 100 μg of
βA3/A1102–117 in a total volume of 0.2 ml of PBS at 37 °C for
12 h. A sample containing αB-crystallin alone served as a
control. After the incubation, samples were briefly
centrifuged to separate any visible precipitate. The
supernatant was injected into a TSK G5000PWXL (Tosoh
Bioscience, Montgomeryville, PA) size exclusion column
fitted to an HPLC system with an ultraviolet (UV) detector
and equilibrated with PBS. The peak containing the αB-
crystallin-peptide complex was pooled (free of unbound
Figure 1. Aggregation-enhancing and
anti-chaperone property of βA3/
A1102-117 peptide. A: The effect of the
βA3/A1102–117 peptide
(SDAYHIERLMSFRPIC) and the
substituted peptide
(SDADHGERLMSFRPIC) on thermal
aggregation of βL-crystallin shown. βL-
crystallin (100 μg) was incubated at 55
°C with 60 μg of the peptides for 60 min.
βA3/A1102-117 peptide enhanced the
light scattering by denaturing βL-
crystallin whereas the substituted
peptide did not. A, βL-crystallin; B, βL-
crystallin + βA3/A1102–117 peptide; C,
βL-crystallin + substituted peptide; D,
βA3/A1102–117 or substituted peptide
alone. B: The effect of βA3/A1102–117
peptide (SDAYHIERLMSFRPIC) and
the substituted peptide
(SDADHGERLMSFRPIC) on the
chaperone-like activity of αB-crystallin
against denaturing βL-crystallin is
illustrated. βL-crystallin (100 μg) was
incubated at 55 °C in the presence of 5
μg of αB-crystallin with or without 60
μg of the peptides for 60 min. In the
presence of βA3/A1102-117 peptide, the
chaperone-like activity of αB-crystallin
against denaturing βL-crystallin was
lost. The substituted peptide however,
did not decrease the chaperone-like
activity of αB-crystallin. A, βL-
crystallin; B, βL-crystallin + αB-
crystallin; C, βL-crystallin + αB-
crystallin + βA3/A1102–117 peptide; D,
βL-crystallin + αB-crystallin +
substituted peptide; E, αB-crystallin +
βA3/A1102–117 or substituted peptide.
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peptide) and used in the chaperone assay as described in the
previous section.
Identification of βA3/A1102–117 peptide binding sites in αB-
crystallin: To identify the βA3/A1102–117 peptide binding sites
in αB-crystallin, the purified peptide was derivatized with
sulfo-SBED, a biotin-containing and photoactivable as well
as heterotrifunctional and amine-group specific reagent [37].
The procedure described by the supplier (Pierce) was used. In
brief, 1.78 mg of βA3/A1 peptide was dissolved in 10 μl
DMSO and the volume was made up to 50 μl with PBS. Then,
2.5 mg of sulfo-SBED dissolved in 10 μl DMSO and made up
to 50 μl with PBS was added to the peptide, and the final
volume of the reaction mixture was made up to 0.3 ml with
phosphate buffer. This achieved a threefold molar excess of
the sulfo-SBED over the peptide. The mixture was incubated
in the dark at room temperature for 45 min. The unreacted
sulfo-SBED was removed by dialyzing extensively against
PBS using a 1000 Da cut-off membrane. Similarly, the
substituted peptide, SDADHGERLMSFRPIC, was
derivatized with sulfo-SBED for use in the interaction studies.
To study the interaction between the sulfo-SBED-
derivatized βA3/A1102–117 peptide (or the substituted peptide)
and αB-crystallin, 0.25 mg of the derivatized peptide was
incubated with 0.25 mg of human recombinant αB-crystallin
at 37 °C for 2 h. Subsequently, the mixture was filtered in a
10,000 Da cut-off centrifugal filter to remove unbound
peptide (all steps were performed in the dark). Following this,
the sample was photolyzed on an ice bath for 15 min using a
UV lamp (365 nm) held at a distance of 2 cm from the sample.
Transfer of the biotin label from the sulfo-SBED-derivatized
peptide to αB-crystallin was confirmed by SDS–PAGE
followed by western blot. The intensities of labeled bands in
blots were quantified using Kodak 1D image analysis
software (Eastman Kodak Company, Rochester, NY). The
labeled αB-crystallin was then reduced by DTT and alkylated
with iodoacetamide. Following this, the sample was dialyzed
extensively for 24 h against 50 mM Tris (pH 7.6) containing
1 mM CaCl2 using a 15,000 Da cut-off membrane and digested
by mass spectrometry grade trypsin (1:25 w/w) at 37 °C for
12 h. Trypsin digestion was terminated by the addition of the
trypsin inhibitor, TLCK (1 mM); the sample was filtered
through a microcon 10 kDa filter (Millipore, Bedford, MA),
and the filtrate was collected. Trypsin-digested αB-crystallin
peptides having the biotin group derived from the sulfo-SBED
cross-linker were isolated by Pierce immobilized monomeric
avidin affinity gel chromatography [37]. The biotin-labeled
peptides were concentrated by Speed Vac, desalted by C-18
spin columns, and analyzed in an Applied Biosystems 4700
MALDI TOF/TOF mass spectrometer. The sequences of the
labeled peptides were determined by nanospray quadrupole
time-of-flight mass spectrometry (QqTOF MS/MS).
RESULTS
Effect of βA3/A1102–117 peptide on the thermal aggregation of
bovine βL-crystallin and the chaperone-like action of αB-
Figure 2. Chaperone-like activity of αB-
crystallin-βA3/A1102–117 peptide
complex against denaturing βL-
crystallin. βL-crystallin (100 μg) was
incubated at 55 °C in presence of 5 μg
and 10 μg of αB-crystallin or αB-
crystallin-βA3/A1102–117 peptide
complex for 60 min and the light
scattering was measured as described
under methods. The results show
that prior interaction of αB-crystallin
with βA3/A1102-117 peptide diminished
its chaperone-like activity against
denaturing βL-crystallin. A, βL-
crystallin; B, βL-crystallin + 5 μg αB-
crystallin; C, βL-crystallin + 10 μg αB-
crystallin; D, βL-crystallin + 5 μg αB-
crystallin-βA3/A1102–117 peptide
complex; E, βL-crystallin + 10 μg αB-
crystallin-βA3/A1102–117 peptide
complex; F, αB-crystallin or αB-
crystallin-βA3/A1102–117 peptide
complex alone. Insert: Relative light
scattering by βL-crystallin in presence of
αB-crystallin or αB-crystallin-βA3/
A1102–117 peptide complex. Scattering
by βL-crystallin alone at 60 min is
considered to be 100%.
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crystallin: The βA3/A1102–117 peptide found in aged lenses is
present in both deamidated (at Asn103) and non-deamidated
forms in vivo. Both the native peptide and the deamidated
form of the same peptide displayed similar anti-chaperone
activity (data not shown here). In this study, we used the
deamidated form of the peptide. Thermal denaturation of βL-
crystallin at 55 °C resulted in aggregation and light scattering.
The addition of the βA3/A1102–117 peptide to the incubation
mixture resulted in increased light scattering by βL-crystallin
by 58% whereas the substituted peptide increased the light
scattering only by 4% at 60 min. The βA3/A1102–117 peptide by
itself did not scatter light (Figure 1A). When the βL-crystallin
was heat-denatured in the presence of αB-crystallin, the light
scattering was decreased by 41% at 60 min due to the
chaperone-like action of αB-crystallin. However, when βL-
crystallin was denatured in the presence of αB-crystallin and
βA3/A1102–117 peptide, the light scattering increased by 20%
showing the decreased chaperone action of αB-crystallin. The
substituted peptide, on the other hand, caused a slight
improvement in the chaperone action of αB-crystallin. The
light scattering by denatured βL-crystallin was decreased by
53% in the presence of αB-crystallin and substituted peptide
(Figure 1B). The αB-crystallin-βA3/A1102–117 peptide complex
showed a lowered ability to prevent thermal aggregation of
βL-crystallin. This complex (5 μg) decreased the light
scattering by heat-denatured βL-crystallin at 60 min by only
3% (Figure 2, curve D) as opposed to a 51% decrease caused
by an equivalent amount of the control, αB-crystallin (Figure
2, curve B). When a higher concentration of αB-crystallin-
βA3/A1102–117 peptide complex (10 μg) was used in the assay,
it caused only a 24% decrease in light scattering (Figure 2,
curve E) compared to the 81% decrease caused by an
equivalent amount of the control, αB-crystallin (Figure 2,
curve C).
Identification of βA3/A1102–117 peptide binding sites in
recombinant αB-crystallin: Photoinsertion of the biotin label
from the derivatized βA3/A1102–117 peptide to αB-crystallin
was confirmed by SDS–PAGE and western blot analysis
(Figure 3, lane 1). The derivatized substituted peptide
incorporated the biotin label into αB-crystallin to a
significantly lesser extent than the native peptide (about 1.2%
of the band intensity in western blot as compared to βA3/
A1102–117 peptide) as seen in Figure 3, lane 2.
To identify the βA3/A1102–117 peptide interacting sites in
αB-crystallin, the tryptic digest of αB-crystallin containing the
biotin-labeled peptides was enriched by immobilized
monomeric avidin affinity gel chromatography. The masses
of the labeled peptides were determined by MALDI TOF/TOF
MS. Since sulfo-SBED contains a cleavable disulfide bond,
reduction and alkylation of the labeled αB-crystallin with
Figure 3. Western blot and SDS–PAGE
of αB-crystallin treated with sulfo-
SBED-derivatized βA3/A1102–117
peptide and substituted peptide. The
blots were probed with avidin-
horseradish peroxidase conjugate, and
detection was done using a mixture of 4-
chloronaphthol and hydrogen peroxide.
Western blot lanes 1 and 2 correspond
to SDS–PAGE of lanes 4 and 5 stained
with Coomassie Blue. Lane 1- αB-
crystallin interacted with sulfo-SBED-
derivatized βA3/A1102–117 peptide; Lane
2- αB-crystallin interacted with sulfo-
SBED-derivatized substituted peptide;
Lane 3- Molecular weight markers;
Lane 4- αB-crystallin interacted with
sulfo-SBED-derivatized βA3/A1102–117
peptide; Lane 5- αB-crystallin
interacted with sulfo-SBED-derivatized
substituted peptide. The arrow indicates
the position of αB-crystallin.
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iodoacetamide will add a net mass of 603.22 Da to the mass
of the αB-crystallin-derived peptide containing the biotin
label. Before assigning the amino acid sequence for each
biotin-labeled αB-crystallin peptide, the presence of biotin
label in those peptides was confirmed by detection of the
fragment ions generating specifically from sulfo-SBED
during MS/MS analysis [34]. MALDI-TOF MS spectra of
biotin-labeled αB-crystallin peptides obtained from
monomeric avidin affinity column is shown in Figure 4. The
peptide peaks labeled in Figure 4 were analyzed further by
nanospray QqTOF MS/MS. The amino acid sequence of those
peptides is indicated in the αB-crystallin sequence in Figure
5. The amino acid sequences of tryptic digest peptides of αB-
crystallin carrying the biotin label and their masses (in
parentheses) were 70LEKDR74 (1263.64 Da),
83HFSPEELKVK92 (1816.93 Da), 91VKVLGDVIEVHGK103
(1996.06 Da), 93VLGDVIEVHGKHEER107 (2320.26 Da),
121KYR123 (1069.51 Da), 150KQVSGPER157 (1503.75 Da),
164EEKPAVTAAPK174 (1743.86 Da), and
164EEKPAVTAAPKK175 (1871.99 Da). A peptide with a mass
of 1388.77 Da without any modifications, corresponding to
residues 1–11 in αB-crystallin, was also found among the
purified peptides.
Figure 4. MALDI-TOF MS spectrum of
biotin-labeled αB-crystallin tryptic
peptides purified by avidin affinity
chromatography. Sulfo-SBED-
derivatized βA3/A1102–117 peptide was
allowed to interact with αB-crystallin
then was photolyzed and digested with
trypsin as described under Methods
before chromatography. Masses of the
αB-crystallin tryptic peptides carrying
the biotin label are indicated in the
figure. The sequences of these
peptides are shown in Figure 5.
Figure 5. Amino acid sequence of αB-
crystallin showing the βA3/A1102–117
peptide interacting sites (underlined).
The chaperone region previously
identified by us is shaded in gray.
Biotin-labeled αB-crystallin peptides
were analyzed by MALDI-TOF MS,
and their sequences were assigned by
nanospray QqTOF MS/MS. The masses
of the biotin-labeled αB-crystallin
peptides are shown adjacent to their
sequences. *NH2-terminal peptide was
consistently observed in the MALDI-
TOF MS without a sulfo-SBED label.
This peptide may be interacting with
other labeled peptides and co-eluting
during the monomeric avidin
purification step.
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DISCUSSION
The presence of crystallin fragments in water-soluble and
water-insoluble fractions of lens proteins has been known for
some years [11,40]. We first suggested that anti-chaperone
peptides accumulating in vivo may be contributing to lens
opacification during aging [33]. Recent studies in our
laboratory have revealed the presence of 23 low molecular
weight (<3.5 kDa) peptides in the urea-soluble fractions of
normal young, normal aged, and aged cataract human lenses,
and the amount of crystallin fragments was found to increase
with age [36]. Our study also showed that βA3/A1102–117
peptide, found in aged and cataract lens, increased the
scattering of light by β- and γ-crystallins and alcohol
dehydrogenase (ADH). βA3/A1102–117 peptide also exhibited
an anti-chaperone property by decreasing the ability of α-
crystallin to prevent aggregation of β- and γ-crystallins and
non-crystallin protein substrates, a process believed to be
essential for maintenance of lens transparency [36].
The present study has confirmed the aggregation-
enhancing property of the βA3/A1-crystallin-derived peptide,
102SDAYHIERLMSFRPIC117, since it promoted the
aggregation of βL-crystallin during thermal denaturation
(Figure 1A). The presence of this peptide in the assay mixture
reduced the ability of αB-crystallin to protect βL-crystallin
against thermal aggregation (Figure 1B). Since the βA3/
A1102–117 peptide interacts with both βL-crystallin and αB-
crystallin, the enhanced light scattering observed in its
presence may be due to a combination of its interaction with
the substrate as well as the chaperone protein. To confirm the
anti-chaperone nature of the peptide, we pretreated αB-
crystallin with βA3/A1102–117 peptide and separated the
complex from the free peptide. The αB-crystallin-βA3/A1102–
117 peptide complex showed a considerable loss of chaperone-
like activity against heat-denatured βL-crystallin (Figure 2).
Since free peptide was removed before the assay, we believe
that the decreased chaperoning ability of αB-crystallin was
specifically due to the binding of the peptide to αB-crystallin.
When the βA3/A1102–117 peptide was derivatized with sulfo-
SBED, incubated with αB-crystallin, and photolyzed, the
biotin label transferred to αB-crystallin (Figure 3, lane 1). The
MALDI-TOF MS of the peptides derived from the αB-
crystallin by trypsin digestion showed the presence of biotin
from sulfo-SBED in several peptides (Figure 4). The identity
of those peptides was obtained by sequencing in a nanospray
QqTOF mass spectrometer. The sites on αB-crystallin where
the label was observed (Figure 5) included the sequences,
70LEKDR74 and 83HFSPEELKVK92. Earlier, we showed that
73DRFSVNLDVKHFSPEELKVK92 is one of the well
characterized functional chaperone sites in αB-crystallin
[41]. Therefore, we can conclude that the anti-chaperone
peptide βA3/A1102–117 binds to αB-crystallin at the chaperone
site. The binding of the βA3/A1102–117 peptide to this substrate-
binding site in αB-crystallin may have diminished the ability
of the protein to effectively chaperone the denaturing βL-
crystallin.
Other sites of interaction between the βA3/A1102–117
peptide and αB-crystallin included the sequences,
91VKVLGDVIEVHGKHEER107 and 121KYR123. These
sequences are part of the α-crystallin domain. Earlier, Arg120
was shown to be important for the chaperone-like activity of
αB-crystallin [42]. A recent study demonstrated that
73DRFSVNLDVKHFS85 and 101HGKHEERQDE110
sequences in αB-crystallin inhibited the fibrillation of disease-
related amyloidogenic proteins including α-synuclein and
amyloid-β [43]. Other binding sites of the βA3/A1 peptide to
αB-crystallin included the COOH-terminal region of
150KQVSGPER157 and 164EEKPAVTAAPKK175. An earlier
study has shown that mutations of the two terminal lysines
(174 and 175) of αB-crystallin to leucine or glycine greatly
reduced its chaperone-like activity. It was postulated that
mutations in these two amino acids may have resulted in the
COOH-terminus folding back on itself, losing its flexibility,
and sterically hindering protein binding [44]. The COOH-
terminal extensions of α-crystallins are considered polar,
highly flexible, and solvent-exposed. These extensions also
act as solubilizing agents for the relatively hydrophobic α-
crystallin molecule and the high molecular weight complex
that forms during the chaperone action [45].
αB-Crystallin with five amino acids deleted from its
COOH-terminus was found in lenses of hereditary cataractous
iCR/f rat, and this truncated crystallin showed decreased
chaperone activity [46]. Protein pin array studies have
identified 157RTIPITRE164 as one of the interactive sequences
for chaperone activity in human αB-crystallin [47]. Deletion
of the polar COOH-terminal sequence, 155PERTIPITREE165,
from human αB-crystallin resulted in poor solubility and
limited or no chaperone activity against unfolding βL-
crystallin, alcohol dehydrogenase, and citrate synthase. These
results demonstrated the importance of the COOH-terminal
residues in the recognition, selection, and maintenance of
solubility of unfolding substrate proteins [48]. As identified
by protein pin-array studies, the 150KQVSGPER157,
164EEKPAVTAAPK174, and 164EEKPAVTAAPKK175
sequences, which are identified as peptide interacting sites in
αB-crystallin in the present study, overlap with sequences
involved in dimerization and assembly of human αB-
crystallin [49]. The binding of the βA3/A1102–117 peptide to the
COOH-terminal extension of αB-crystallin in the present
study may have interfered with substrate binding and
decreased the chaperoning ability of the protein. Our recent
studies showed that the βA3/A1102–117 peptide caused partial
precipitation of αB-crystallin [36]. We believe that the peptide
interaction at the COOH-terminal extension of αB-crystallin
may have led to decreased flexibility and decreased
solubilization potential of αB-crystallin. Additionally, the
interactions between crystallins and low molecular weight
Molecular Vision 2008; 14:666-674 <http://www.molvis.org/molvis/v14/a80> © 2008 Molecular Vision
672
peptides may limit the access of these peptides to peptidases,
resulting in the accumulation of peptides with aging.
The substituted peptide we used in this study,
SDADHGERLMSFRPIC, had two hydrophobic residues
(tyrosine and isoleucine) replaced by hydrophilic (aspartate
and glycine) residues. The substitution abolished the ability
of the peptide to induce βL-crystallin aggregation (Figure 1A)
and to act as anti-chaperone (Figure 1B). This suggests that
the hydrophobic amino acids play a critical role in the
interaction of the anti-chaperone peptide with αB-crystallin.
The substituted peptide can also be considered a control
peptide for the label transfer study. If there were any non-
specific interactions between the derivatized substituted
peptide and αB-crystallin, we would have seen a transfer of
biotin to αB-crystallin following photolysis. The fact that the
αB-crystallin incubated with derivatized substituted peptide
showed only about 1.2% of the label transfer when compared
to the derivatized βA3/A1102–117 peptide during the blotting
experiments (Figure 3 lane 2) suggests that the non-specific
interaction and label transfer was insignificant in this study.
In summary, this study confirmed the interactions
between βA3/A1102–117 peptide and αB-crystallin. The binding
of this peptide to regions critical for chaperone action of αB-
crystallin may explain its anti-chaperone property. The
modulation of structural and functional properties of
crystallins by low molecular weight peptides may play an
important role in protein aggregation and cataract formation.
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